Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1894 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 

    Article Cited by others

EDITORIAL

Calcineurin Inhibitor-Free Protocols: Risks and Benefits

Barbari A G, Stephan A G, Masri M A

Year : 2007| Volume: 18| Issue : 1 | Page no: 1-23

   This article has been cited by
 
1 Posttransplant hypertension: Multipathogenic disease process
Barbari, A.
Experimental and Clinical Transplantation. 2013; 11(2): 99-108
[Pubmed]  [Google Scholar]
2 Optimal blood concentration of cyclosporine among Iranian kidney transplant recipients
Rostami, Z. and Einollahi, B. and Teimoori, M.
Iranian Journal of Kidney Diseases. 2012; 6(5): 373-379
[Pubmed]  [Google Scholar]
3 A pilot study on area under curve of mycophenolic acid as a guide for its optimal use in renal transplant recipients
Sarangi, S.C. and Reeta, K.H. and Agarwal, S.K. and Kaleekal, T. and Guleria, S. and Gupta, Y.K.
Indian Journal of Medical Research. 2012; 135(1): 84-91
[Pubmed]  [Google Scholar]
4 Sirolimus as renal and immunological rescue agent in pediatric liver transplant recipients
Basso, M.-S. and Subramaniam, P. and Tredger, M. and Verma, A. and Heaton, N. and Rela, M. and Mieli-Vergani, G. and Dhawan, A.
Pediatric Transplantation. 2011; 15(7): 722-727
[Pubmed]  [Google Scholar]
5 Effects of cyclosporine A and tacrolimus on blood lipid of renal transplant recipients
Guo, J. and Qu, Q.-S. and Zhu, M.-H. and Liu, X.-H.
Journal of Clinical Rehabilitative Tissue Engineering Research. 2010; 14(44): 8207-8210
[Pubmed]  [Google Scholar]
6 Expression and significance of transforming growth factor-beta 1, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in the renal tissue of patients with chronic allograft nephropathy
Han, C.-X. and Xie, Q.-X. and Zhao, L. and Li, J.-Y. and Lin, X.-C.
Journal of Clinical Rehabilitative Tissue Engineering Research. 2009; 13(5): 821-824
[Pubmed]  [Google Scholar]
7 Reducing calcineurin inhibitor and adding Sirolimus to treat chronic allograft nephropathy
Huo, W.-Q. and Li, Q.-S. and Jin, F.-S. and Nie, Z.-L. and Zhu, F.-Q. and Zhang, K.-Q.
Journal of Clinical Rehabilitative Tissue Engineering Research. 2008; 12(53): 10453-10456
[Pubmed]  [Google Scholar]
8 Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation
Danger, R. and Giral, M. and Soulillou, J.-P. and Brouard, S.
Current Opinion in Organ Transplantation. 2008; 13(6): 609-613
[Pubmed]  [Google Scholar]
9 Susceptibility of human mesenchymal stem cells to tacrolimus, mycophenolic acid, and rapamycin
Hoogduijn, M.J. and Crop, M.J. and Korevaar, S.S. and Peeters, A.M.A. and Eijken, M. and Maat, L.P.W.M. and Balk, A.H.M.M. and Weimar, W. and Baan, C.C.
Transplantation. 2008; 86(9): 1283-1291
[Pubmed]  [Google Scholar]
10 Gingival status of Brazilian renal transplant recipients under sirolimus-based regimens
Cota, L.O.M. and Oliveira, A.P.L. and Costa, J.E. and Cortelli, S.C. and Costa, F.O.
Journal of Periodontology. 2008; 79(11): 2060-2068
[Pubmed]  [Google Scholar]
11 Health-related quality of life in adult transplant recipients more than 15 years after orthotopic liver transplantation
Kousoulas, L. and Neipp, M. and Barg-Hock, H. and Jackobs, S. and Strassburg, C.P. and Klempnauer, J. and Becker, T.
Transplant International. 2008; 21(11): 1052-1058
[Pubmed]  [Google Scholar]
12 Immune modulation in corneal transplantation
Fu, H. and Larkin, D.F.P. and George, A.J.T.
Transplantation Reviews. 2008; 22(2): 105-115
[Pubmed]  [Google Scholar]
13 A novel approach in clinical immunosuppression monitoring: Drug lymphocyte level
Barbari, A. and Masri, M. and Stephan, A. and Rizk, S. and Younan, F.
Experimental and Clinical Transplantation. 2007; 5(2): 643-648
[Pubmed]  [Google Scholar]

 

Read this article